JAPAN AS REPRESENTED BY DIRECTOR GENERAL OF NATIONAL INSTITUTE OF INFECTIOUS DISEASES

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 12243
 
  
 
C07K PEPTIDES 12124
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 9158
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 1153
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0015,800 NASAL INFLUENZA VACCINE COMPOSITIONOct 23, 13Jan 21, 16[A61K, C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9814785 Hepatitis C virus liposome vaccineAug 20, 15Nov 14, 17[A61K, C12N]
9603919 Method for prophylaxis of influenza using vaccine for intranasal administrationMar 31, 10Mar 28, 17[A61K, C12N, C07K]
9453056 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 3aAug 31, 12Sep 27, 16[C12Q, C12N, G01N, C07K]
9234184 Nucleic acid construct comprising nucleic acid derived from genome of hepatitis C virus of genotype 1B, hepatitis C virus genome-replicating cells transfected with the same, and method for producing infectious hepatitis C virus particlesMar 30, 12Jan 12, 16[A61K, C12Q, C12N, C07K]
9186383 Mutant replicon derived from genome of hepatitis C virus J6CF strainMay 31, 12Nov 17, 15[A61K, C12N, C07K]
9057048 Infectious hepatitis C virus—high producing HCV variants and use thereofMar 25, 11Jun 16, 15[A61K, C12N, C07K]
8993228 Antibody binding to envelope protein 2 of hepatitis C virus and method for identifying genotype of hepatitis C virus using the sameSep 30, 09Mar 31, 15[A61K, G01N, C07K]
8949033 Method for quantification of neurotoxinApr 28, 06Feb 03, 15[G01N]
8834893 Nucleic acid derived from hepatitis C virus and expression vector, transformed cell, and hepatitis C virus particles each prepared by using the sameDec 25, 09Sep 16, 14[A61K, C12N, C07K]
8828929 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereofNov 27, 09Sep 09, 14[A61K, A61P, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0107,273 ANTIBODY HAVING INFECTION-INHIBITING ACTIVITY AGAINST HEPATITIS C VIRUSAbandonedMar 20, 15Apr 20, 17[C07K]
2015/0344,529 VACCINE FOR HPV INFECTION AND/OR HEPATITIS B COMPRISING HPV/HBS CHIMERIC PROTEIN AS ACTIVE INGREDIENTAbandonedNov 28, 13Dec 03, 15[C07K]
2014/0065,180 WEST NILE VIRUS VACCINE, AND METHOD FOR PRODUCTION THEREOFAbandonedNov 04, 13Mar 06, 14[A61K]
2014/0046,034 ANTIBODY HAVING ACTIVITY OF INHIBITING HEPATITUS C VIRUS (HCV) INFECTION AND USE THEREOFAbandonedOct 22, 13Feb 13, 14[C07K]
8604179 Nucleic acid comprising chimeric gene derived from hepatitis C virusExpiredApr 24, 09Dec 10, 13[A61K, C12N, C07K]
8592559 Antibody having activity of inhibiting hepatitis C virus (HCV) infection and use thereofExpiredOct 29, 10Nov 26, 13[C07K]
8577618 Method for quantification of neurotoxinWithdrawnApr 28, 06Nov 05, 13[G01N]
2013/0183,376 HEPATITIS C VIRUS LIPOSOME VACCINEAbandonedSep 07, 11Jul 18, 13[A61K]
2012/0251,572 HEPATITIS C VIRUS VACCINE COMPOSITIONAbandonedSep 30, 10Oct 04, 12[A61K, A61P]
8143022 High production system for infectious hepatitis C virus particleExpiredSep 29, 06Mar 27, 12[C12P, C12N]
2011/0105,940 METHOD FOR QUANTIFICATION OF TITER OF NEUTRALIZING ANTIBODY TO NEUROTOXINAbandonedAug 20, 08May 05, 11[A61B]
2010/0291,545 ANTIBODY HAVING INHIBITORY ACTIVITY ON INFECTION WITH HEPATITIS C VIRUS (HCV) AND USE THEREOFAbandonedJul 25, 08Nov 18, 10[C12Q, C07K]
2010/0278,865 PRODUCTION AND USE OF EPITOPE-TAGGED HEPATITIS C VIRUS PARTICLEAbandonedJul 11, 08Nov 04, 10[A61K, C07H, C12N, A61P, C07K]
2009/0214,596 Nasal VaccineAbandonedMar 30, 06Aug 27, 09[A61K, A61P]
2007/0219,149 Novel Vaccine Containing Adjuvant Capable Of Inducing Mucosal ImmunityAbandonedAug 10, 04Sep 20, 07[A61K]
2006/0275,329 Flavin protein of trypanosoma cruzi, method of screening vermicide with the use of the same and diagnosticAbandonedOct 10, 03Dec 07, 06[C07H, A61K, C12Q, C12N, C07K]
2004/0213,802 Gene of novel corynebacterium diphtheriae antigenAbandonedFeb 24, 04Oct 28, 04[A61K, C07H, C12N, C07K]
2002/0002,143 AIDS virus vaccines using sendai virus vectorAbandonedMar 30, 01Jan 03, 02[A61K, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.